연구동향 분석

Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study

Hernández-Vásquez Akram Azañedo Diego Vargas-Fernánde Rodrigo Bendezu-Quispe Guido 2020년

논문상세정보
인용/피인용
' Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • COVID-19
  • Severe acute respiratory syndrome coronavirus 2
  • co-morbidity
  • mexico
  • multimorbidity
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
5,860 0

0.0%

' Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study' 의 참고문헌

  • The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal?
  • The clinical and chest CT features associated with severe and critical COVID-19 pneumonia
    Li K [2020]
  • Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China
    Wu C [2020]
  • Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2 : a systematic review and meta-analysis
    Yang J [2020]
  • Predictors of severe or lethal COVID-19, including angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, in a sample of infected Italian citizens
    Bravi F [2020]
  • Obesity and its implications for COVID-19 mortality
    Dietz W [2020]
  • Noncommunicable diseases (NCD) country profiles 2018
  • Multimorbidity and mortality in older adults : a systematic review and meta-analysis
    Nunes BP [2016]
  • Maps & trends
  • Kidney disease is associated with in-hospital death of patients with COVID-19
    Cheng Y [2020]
  • Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia
    Sun ML [2020]
  • Hypothesis : angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
    Diaz JH [2020]
  • Hypertension in Mexican adults: prevalence, diagnosis and type of treatment. Ensanut MC 2016
    Nonato IC [2018]
  • Host susceptibility to severe COVID-19 and establishment of a host risk score : findings of 487 cases outside Wuhan
    Shi Y [2020]
  • Endothelial cell infection and endotheliitis in COVID-19
    Varga Z [2020]
  • Disability, quality of life and all-cause mortality in older Mexican adults: association with multimorbidity and frailty
  • Disability, more than multimorbidity, was predictive of mortality among older persons aged 80 years and older
    Landi F [2010]
  • Coronaviruses and immunosuppressed patients : the facts during the third epidemic
  • Coronavirus Disease 2019 (COVID-19)
  • Comorbidity and its impact on 1590 patients with COVID-19 in China : a nationwide analysis
    Guan WJ [2020]
  • Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
    Huang C [2020]
  • Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study
    Zhou F [2020]
  • Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
    Yang X [2020]
  • Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
    Mo P [2020]
  • Clinical characteristics of coronavirus disease 2019 in China
    Guan WJ [2020]
  • Clinical characteristics of 138hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China
    Wang D [2020]
  • Clinical characteristics of 113 deceased patients with coronavirus disease 2019 : retrospective study
    Chen T [2020]
  • Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019(COVID-19)
    Lippi G [2020]
  • Chronic kidney disease is associated with severe coronavirus disease 2019(COVID-19)infection
    Henry BM [2020]
  • Care of patients with liver disease during the COVID-19 pandemic : EASL-ESCMID position paper
    Boettler T [2020]
  • COVID-19 illness in native and immunosuppressed states : a clinical-therapeutic staging proposal
    Siddiqi HK [2020]
  • COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?
    Patel AB [2020]
  • COVID 19 and the patient with obesity-the editors speak out
    Ryan DH [2020]
  • Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection
    Fang L [2020]
  • Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
    Liu W [2020]